Insomnia Severity Index Calculator
Free Insomnia severity index Calculator with medically-sourced formulas. Enter your measurements for personalized, accurate health insights.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
ISI Total = Sum of 7 items (0-4 each, max 28)
Seven items are rated 0-4: three nighttime symptom items (difficulty falling asleep, staying asleep, early awakening), sleep satisfaction, noticeability of impairment, distress level, and interference with daily functioning. Total 0-7: No insomnia, 8-14: Subthreshold, 15-21: Moderate clinical, 22-28: Severe clinical insomnia.
Worked Examples
Example 1: Moderate Clinical Insomnia Assessment
Problem:A 45-year-old woman rates: Difficulty falling asleep=3, Staying asleep=2, Early waking=2, Satisfaction=3, Noticeable to others=2, Worried=3, Interferes with daily life=2. Calculate ISI.
Solution:Item scores: 3 + 2 + 2 + 3 + 2 + 3 + 2 = 17 Total ISI = 17 out of 28 Nighttime symptoms: 3+2+2 = 7/12 Satisfaction: 3/4 Daytime impact: 2+3+2 = 7/12 Classification: Clinical Insomnia (Moderate), score 15-21 Treatment: CBT-I recommended as first-line therapy.
Result:ISI Score: 17/28 | Clinical Insomnia (Moderate) | CBT-I recommended
Example 2: Post-Treatment Follow-Up Assessment
Problem:After 6 weeks of CBT-I, the same patient re-scores: Falling asleep=1, Staying asleep=1, Early waking=1, Satisfaction=1, Noticeable=0, Worried=1, Interferes=1. Calculate ISI and treatment response.
Solution:Item scores: 1 + 1 + 1 + 1 + 0 + 1 + 1 = 6 Total ISI = 6 out of 28 Pre-treatment ISI = 17, Post-treatment ISI = 6 Change = -11 points (clinically significant: >= 6 point reduction) Post-treatment score <= 7 = Remission achieved Classification: No Clinically Significant Insomnia
Result:ISI Score: 6/28 | Remission Achieved | 11-point improvement from CBT-I treatment
Frequently Asked Questions
What is the Insomnia Severity Index and how is it scored?
The Insomnia Severity Index (ISI) is a brief, validated self-report questionnaire developed by Dr. Charles Morin in 1993 to assess the nature, severity, and impact of insomnia over the past two weeks. It consists of 7 items, each rated on a scale of 0 to 4, producing a total score ranging from 0 to 28. The first three items assess the severity of sleep onset difficulty, sleep maintenance difficulty, and early morning awakening. The remaining four items evaluate sleep satisfaction, interference with daily functioning, noticeability of impairment to others, and level of distress caused by the sleep problem. The ISI is widely used in both clinical practice and research settings.
How are ISI scores categorized into severity levels?
ISI total scores are divided into four clinical categories that guide treatment decisions. A score of 0 to 7 indicates no clinically significant insomnia, meaning the individual has normal sleep patterns or very minor sleep complaints that do not require treatment. A score of 8 to 14 represents subthreshold insomnia, where some sleep difficulties exist but may not meet full diagnostic criteria for an insomnia disorder. A score of 15 to 21 indicates clinical insomnia of moderate severity, warranting active treatment intervention. A score of 22 to 28 represents severe clinical insomnia requiring comprehensive treatment. These cutoffs have been validated against clinical interviews and polysomnography data.
What causes chronic insomnia and who is at risk?
Chronic insomnia has multiple contributing factors often explained by the 3P model: predisposing, precipitating, and perpetuating factors. Predisposing factors include genetic tendency toward hyperarousal, female sex, advancing age, and personality traits such as perfectionism and neuroticism. Precipitating factors are stressful life events, medical illness, pain, medication changes, or major schedule disruptions that trigger the initial insomnia episode. Perpetuating factors are maladaptive behaviors adopted in response to insomnia, such as spending excessive time in bed, irregular sleep schedules, napping, caffeine use, and anxious rumination about sleep. Approximately 10 to 15 percent of adults worldwide suffer from chronic insomnia disorder, with women affected twice as often as men.
What is cognitive behavioral therapy for insomnia (CBT-I)?
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment recommended by the American College of Physicians, the American Academy of Sleep Medicine, and the European Sleep Research Society for chronic insomnia disorder. CBT-I typically consists of 4 to 8 sessions and includes multiple components: sleep restriction therapy (limiting time in bed to match actual sleep time), stimulus control (strengthening the bed-sleep association), sleep hygiene education, cognitive restructuring (addressing unhelpful beliefs about sleep), and relaxation training. Research consistently shows that CBT-I produces sustained improvements equal to or greater than sleep medications, with typical ISI score reductions of 8 to 10 points and treatment response rates of 70 to 80 percent.
How does the ISI compare to other insomnia assessment tools?
Several validated tools assess insomnia, each with different strengths. The Pittsburgh Sleep Quality Index (PSQI) is a 19-item questionnaire measuring sleep quality over the past month across seven domains, providing a broader assessment but taking longer to complete. The Athens Insomnia Scale (AIS) is an 8-item measure based on ICD-10 criteria. The Sleep Condition Indicator (SCI) was designed around DSM-5 insomnia diagnostic criteria. The ISI is particularly valued for its brevity (7 items), strong psychometric properties, sensitivity to treatment change, and established clinically meaningful cutoffs. It is the most commonly used outcome measure in insomnia treatment studies and is recommended by consensus guidelines for routine clinical assessment.
Can the ISI be used to monitor treatment progress?
Yes, the ISI is specifically designed to be sensitive to treatment-related changes and is the most widely used outcome measure in insomnia clinical trials. A reduction of 6 or more points on the ISI is considered a clinically meaningful treatment response, while achieving a post-treatment score of 7 or below is considered remission of insomnia. Serial administration at baseline, during treatment, and at follow-up provides objective documentation of treatment effectiveness. In CBT-I studies, the ISI typically shows significant improvement within the first 2 to 3 weeks of treatment, with continued gains through the full treatment course. The ISI can be readministered at each clinical visit to track progress and adjust treatment strategies accordingly.
What is the relationship between insomnia and mental health?
Insomnia and mental health disorders have a bidirectional relationship, meaning each condition can cause or worsen the other. Approximately 40 to 50 percent of individuals with chronic insomnia also have a comorbid psychiatric disorder, most commonly depression, anxiety, or post-traumatic stress disorder (PTSD). Insomnia is a significant risk factor for developing major depression, with insomnia sufferers having a two-fold increased risk of future depression. Conversely, depression and anxiety frequently cause or exacerbate insomnia through hyperarousal, rumination, and altered neurotransmitter function. Treating insomnia with CBT-I has been shown to improve comorbid depression and anxiety symptoms even without direct treatment of those conditions. This evidence has shifted the clinical approach from viewing insomnia as merely a symptom to treating it as an independent condition.
Are sleeping pills effective for treating insomnia?
Sleep medications (hypnotics) can provide short-term relief for insomnia but have significant limitations for long-term management. Benzodiazepine receptor agonists such as zolpidem, eszopiclone, and zaleplon can reduce sleep onset latency by 10 to 20 minutes and improve ISI scores by 4 to 6 points in the short term. However, these medications carry risks including tolerance development, physical dependence, rebound insomnia upon discontinuation, next-day cognitive impairment, falls in elderly patients, and potential for complex sleep behaviors. The orexin receptor antagonists suvorexant and lemborexant represent a newer class with potentially fewer dependence concerns. Guidelines recommend medications only when CBT-I is unavailable, has failed, or as a short-term bridge while initiating behavioral treatment.
How does insomnia affect physical health and daily functioning?
Chronic insomnia has far-reaching consequences beyond nighttime sleep disruption. Cognitively, insomnia impairs attention, working memory, executive function, and decision-making, with performance deficits comparable to mild alcohol intoxication. Physically, chronic sleep loss increases inflammatory markers, impairs immune function, elevates cortisol levels, and disrupts glucose metabolism. Studies show insomnia increases the risk of hypertension by 300 to 500 percent, type 2 diabetes by 28 to 57 percent, and cardiovascular events by 45 percent. Work productivity losses from insomnia cost the US economy an estimated 63 billion dollars annually through absenteeism and presenteeism. Chronic insomnia also increases the risk of workplace accidents and motor vehicle crashes by 200 to 300 percent.
What sleep hygiene practices can help improve ISI scores?
While sleep hygiene alone is often insufficient for clinical insomnia, it forms an important foundation for treatment. Key practices include maintaining a consistent wake time seven days a week (the single most important habit), avoiding caffeine after noon and alcohol within 3 hours of bedtime, creating a cool (65 to 68 degrees Fahrenheit), dark, and quiet sleep environment, limiting screen exposure for 30 to 60 minutes before bed due to blue light suppression of melatonin, engaging in regular physical activity but not within 2 to 3 hours of bedtime, and avoiding clock-watching during the night. The bedroom should be reserved for sleep and intimacy only, removing TVs, computers, and work materials. These practices typically reduce ISI scores by 2 to 4 points when implemented consistently.
References
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist · Editorial policy
Related Calculators
🧮BMI Calculator - Body Mass Index
Calculate bmicalculator body mass index with inputs, formulas, and instant results.
🧮BRI Calculator - Body Roundness Index
Calculate bricalculator body roundness index with inputs, formulas, and instant results.
🧮Cardiac Index Calculator
Calculate cardiac index with inputs, formulas, and instant results.
🧮Duke Activity Status Index Calculator
Calculate duke activity status index with inputs, formulas, and instant results.
🧮Glycemic Index Calculator
Calculate glycemic index with inputs, formulas, and instant results.
🧮Pearl Index Calculator
Calculate pearl index with inputs, formulas, and instant results.
🧮Hearing Loss Calculator — dB Loss & Severity Grade
Calculate hearing loss with inputs, formulas, and instant results.
🧮FFMI Calculator
Calculate your Fat-Free Mass Index to evaluate muscular development relative to height.